A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
Authors: Vydra J; Institute of Haematology and Blood Transfusion, Prague, Czech Republic., Cosimo E; TC BioPharm, Motherwell, UK., Lesný P; Institute of Haematology and Blood Transfusion, Prague, Czech Republic., Wanless RS; TC BioPharm, Motherwell, UK., Anderson J; UCL Institute of Child Health, London, UK., Clark AG; TC BioPharm, Motherwell, UK., Scott A; TC BioPharm, Motherwell, UK., Nicholson EK; The Royal Marsden Hospital, London, UK., Leek M; TC BioPharm, Motherwell, UK.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 May; Vol. 23 (5), pp. e232-e239. Date of Electronic Publication: 2023 Feb 11.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36863897
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vydra+J%22">Vydra J</searchLink>; Institute of Haematology and Blood Transfusion, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Cosimo+E%22">Cosimo E</searchLink>; TC BioPharm, Motherwell, UK.<br /><searchLink fieldCode="AU" term="%22Lesný+P%22">Lesný P</searchLink>; Institute of Haematology and Blood Transfusion, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Wanless+RS%22">Wanless RS</searchLink>; TC BioPharm, Motherwell, UK.<br /><searchLink fieldCode="AU" term="%22Anderson+J%22">Anderson J</searchLink>; UCL Institute of Child Health, London, UK.<br /><searchLink fieldCode="AU" term="%22Clark+AG%22">Clark AG</searchLink>; TC BioPharm, Motherwell, UK.<br /><searchLink fieldCode="AU" term="%22Scott+A%22">Scott A</searchLink>; TC BioPharm, Motherwell, UK.<br /><searchLink fieldCode="AU" term="%22Nicholson+EK%22">Nicholson EK</searchLink>; The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Leek+M%22">Leek M</searchLink>; TC BioPharm, Motherwell, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2023 May; Vol. 23 (5), pp. e232-e239. <i>Date of Electronic Publication: </i>2023 Feb 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36863897
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clml.2023.02.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e232
    Titles:
      – TitleFull: A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vydra J
      – PersonEntity:
          Name:
            NameFull: Cosimo E
      – PersonEntity:
          Name:
            NameFull: Lesný P
      – PersonEntity:
          Name:
            NameFull: Wanless RS
      – PersonEntity:
          Name:
            NameFull: Anderson J
      – PersonEntity:
          Name:
            NameFull: Clark AG
      – PersonEntity:
          Name:
            NameFull: Scott A
      – PersonEntity:
          Name:
            NameFull: Nicholson EK
      – PersonEntity:
          Name:
            NameFull: Leek M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2152-2669
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical lymphoma, myeloma & leukemia
              Type: main
ResultId 1